Lymfeklinikken ApS — Credit Rating and Financial Key Figures

Lymfeklinikken ApS (CVR number: 43221140) is a company from HVIDOVRE. The company recorded a gross profit of 43.2 kDKK in 2023. The operating profit was -6.9 kDKK, while net earnings were -6.8 kDKK. The profitability of the company measured by Return on Assets (ROA) was -12.2 %, which can be considered poor and Return on Equity (ROE) was -21 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 39.8 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. Lymfeklinikken ApS's liquidity measured by quick ratio was 1.7 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.